| Company Name | Logo | Symbol | Rating ⓘ | Shares (M) | Final Price | Price Range | Underwriter(s) | Offer Amount | Expected |
|---|---|---|---|---|---|---|---|---|---|
|
Scribe Therapeutics, Inc.
|
|
SCTX | Unlock Rating for Free ⓘ | 7.15M | $13.00-$15.00 | Leerink Partners, Goldman Sachs, Guggenheim, Wells Fargo | $100.00M | 07/24/2026 | |
|
Jersey Mikes Subs Inc.
|
|
JMKE | Unlock Rating for Free ⓘ | 43.48M | $21.00 - $25.00 | Morgan Stanley, Jefferies, J.P. Morgan | $1.00B | 07/31/2026 | |
|
Reformation Inc.
|
|
REF | Unlock Rating for Free ⓘ | 14.06M | $15.00-$17.00 | J.P. Morgan, Morgan Stanley | $225.00M | 07/31/2026 | |
|
Apnimed, Inc.
|
|
APMD | Unlock Rating for Free ⓘ | BofA Securities, Evercore ISI, Cantor | $100.00M | Q3 2026 | |||
|
Attovia Therapeutics Inc
|
|
ATTO | Unlock Rating for Free ⓘ | Morgan Stanley, Leerink Partners, Citigroup, RBC Capital Markets | $100.00M | Q3 2026 | |||
|
BlossomHill Therapeutics Inc.
|
|
BLSM | Unlock Rating for Free ⓘ | J.P. Morgan, Leerink Partners, Guggenheim, LifeSci Capital, H.C. Wainwright | $100.00M | Q3 2026 | |||
|
Braveheart Bio Inc.
|
|
BRVE | Unlock Rating for Free ⓘ | Goldman Sachs, Jefferies, TD Cowen, Stifel, Cantor | $100.00M | Q3 2026 | |||
|
Cumberland Farms Ltd.
|
|
CMBY | Unlock Rating for Free ⓘ | BofA Securities, Goldman Sachs, Jefferies | $100.00M | Q3 2026 | |||
|
Entrata, Inc.
|
|
ENT | Unlock Rating for Free ⓘ | Goldman Sachs, J.P. Morgan, Barclays | $100.00M | Q3 2026 | |||
|
Genneia S.A.
|
|
GENN | Unlock Rating for Free ⓘ | Morgan Stanley, BTG Pactual | $100.00M | Q3 2026 | |||
|
Holtec Nuclear Corporation
|
|
HNUC | Unlock Rating for Free ⓘ | J.P. Morgan, Guggenheim, Goldman Sachs, Citigroup, BofA Securities | $100.00M | Q3 2026 | |||
|
Latigo Biotherapeutics Inc.
|
|
LTGO | Unlock Rating for Free ⓘ | Goldman Sachs, Jefferies, Leerink Partners, Guggenheim | $100.00M | Q3 2026 | |||
|
Londian Wason New Energy Tech Inc.
|
|
TBD | Unlock Rating for Free ⓘ | Cantor | $100.00M | Q3 2026 | |||
|
Syntiant Corp.
|
|
SYTN | Unlock Rating for Free ⓘ | Citigroup, BofA Securities, UBS Investment Bank | $100.00M | Q3 2026 | |||
|
Tailored Brands, Inc.
|
|
MENW | Unlock Rating for Free ⓘ | Goldman Sachs, Morgan Stanley, Jefferies | $100.00M | Q3 2026 | |||
|
YPF Energía Eléctrica S.A.
|
|
YLUZ | Unlock Rating for Free ⓘ | Goldman Sachs, BofA Securities, Citigroup | $100.00M | Q3 2026 |